Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anabella Smulever

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Reviews in Endocrine & Metabolic Disorders|August 30, 2023
Advances in the management of anaplastic thyroid carcinoma: transforming a life-threatening condition into a potentially treatable diseaseInés Califano, Anabella Smulever, Fernando Jerkovich, et al.
European Thyroid Journal|August 9, 2017
Should Age at Diagnosis Be Included as an Additional Variable in the Risk of Recurrence Classification System in Patients with Differentiated Thyroid CancerFabián Pitoia, Fernando Jerkovich, Anabella Smulever, et al.
Archives of Endocrinology and Metabolism|October 18, 2024
Implementing active surveillance for low-risk thyroid carcinoma into clinical practice: collaborative recommendations for Latin AmericaAlvaro Sanabria, Carolina Ferraz, Chih Hao Chen Ku, et al.
Endocrine|January 8, 2023
Dabrafenib plus trametinib treatment in patients with anaplastic thyroid carcinoma: an Argentinian experienceFernanda Bueno, Anabella Smulever, Inés Califano, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Reviews in Endocrine & Metabolic Disorders|August 30, 2023
Advances in the management of anaplastic thyroid carcinoma: transforming a life-threatening condition into a potentially treatable diseaseInés Califano, Anabella Smulever, Fernando Jerkovich, et al.
European Thyroid Journal|August 9, 2017
Should Age at Diagnosis Be Included as an Additional Variable in the Risk of Recurrence Classification System in Patients with Differentiated Thyroid CancerFabián Pitoia, Fernando Jerkovich, Anabella Smulever, et al.
Archives of Endocrinology and Metabolism|October 18, 2024
Implementing active surveillance for low-risk thyroid carcinoma into clinical practice: collaborative recommendations for Latin AmericaAlvaro Sanabria, Carolina Ferraz, Chih Hao Chen Ku, et al.
Endocrine|January 8, 2023
Dabrafenib plus trametinib treatment in patients with anaplastic thyroid carcinoma: an Argentinian experienceFernanda Bueno, Anabella Smulever, Inés Califano, et al.
Pageof 2